Merck & Co., Inc.

Pharmaceutical Preparations·RAHWAY, NJ·FY end 12/31·CIK 310158

Board of Directors

13 members · 12 independent · FY 2025

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
Douglas M. Baker, Jr.	Director	4y	67	AuditResearch		$350,000
Mary Ellen Coe	Director	7y	59	CompResearch		$340,000
Pamela J. Craig	Director	11y	69	AuditNCG		$405,000
Robert M. Davis	CEO and Director	5y	59	—	—	—
Thomas H. Glocer	Lead Independent Director	19y	66	CompNCG		$415,000
Surendralal L. Karsanbhai	Director	1y	56	AuditNCG		$405,000
Risa J. Lavizzo-Mourey	Director	6y	71	CompResearch		$340,000
Stephen L. Mayo	Director	5y	64	AuditResearch		$350,000
Paul B. Rothman	Director	11y	68	AuditResearch		$405,000
Patricia F. Russo	Director	31y	73	CompNCG		$365,000
Christine E. Seidman	Director	6y	73	AuditResearch		$385,000
Inge G. Thulin	Director	8y	72	CompNCG		$340,000
Kathy J. Warden	Director	6y	54	CompNCG		$340,000

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.